Guidelines for Perioperative Temperature Management

Abstract

Perioperative temperature management is a critical aspect of anesthetic and surgical care, directly impacting patient outcomes. Hypothermia and hyperthermia during the perioperative period are associated with increased morbidity, including surgical site infections, cardiovascular complications, and impaired drug metabolism. This review synthesizes the latest evidence and guideline recommendations regarding the prevention, diagnosis, and management of perioperative temperature disturbances, offering practical insights for clinicians. Emphasis is placed on understanding the epidemiology, pathophysiology, risk factors, and current best practices, with a focus on the integration of recent advances and emerging technologies into clinical protocols. The article aims to provide a comprehensive, guideline-driven approach for optimizing temperature management across diverse surgical populations.

Introduction

Maintaining normothermia throughout the perioperative period is a cornerstone of safe anesthetic and surgical practice. Both inadvertent hypothermia and, less commonly, hyperthermia are prevalent challenges that can adversely affect patient outcomes. The perioperative environment—encompassing preoperative, intraoperative, and postoperative phases—presents unique risks for temperature dysregulation due to anesthesia-induced thermoregulatory impairment, exposure to cold environments, and surgical factors. Despite advances in monitoring and warming technologies, temperature disturbances remain under-recognized and undertreated in many clinical settings. This article reviews the current state of knowledge and practical guidelines for perioperative temperature management, drawing from recent clinical trials, meta-analyses, and consensus statements from leading professional societies.

Epidemiology / Disease Burden

Perioperative hypothermia, typically defined as a core body temperature below 36°C, occurs in up to 70% of patients undergoing general anesthesia without active warming interventions. The prevalence is highest in major surgeries, procedures involving large fluid shifts, and in vulnerable populations such as neonates, the elderly, and those with low body mass index. Surgical site infections, increased bleeding, delayed drug metabolism, prolonged recovery, and cardiovascular events are some of the well-documented sequelae of perioperative hypothermia. Hyperthermia, while less common, may arise in specific scenarios such as malignant hyperthermia, sepsis, or excessive external warming. The economic burden includes increased length of hospital stay, readmissions, and resource utilization, underscoring the importance of effective temperature management protocols.

Pathophysiology

The pathophysiology of perioperative hypothermia is multifactorial. Anesthetic agents impair hypothalamic thermoregulation, lowering the threshold for vasoconstriction and shivering while promoting peripheral vasodilation. This redistribution of core body heat to the periphery leads to rapid intraoperative heat loss. Additional mechanisms include evaporation from exposed surfaces, convection from ambient air, radiation, and conductive losses to the operating table. Hypothermia impairs coagulation through platelet dysfunction and decreased enzymatic activity, exacerbates metabolic acidosis, and alters immune responses. Hyperthermia, conversely, may result from excessive warming, underlying infection, or rare pharmacogenetic disorders, leading to cellular injury, coagulopathy, and multiorgan dysfunction if uncorrected.

Risk Factors

Risk factors for perioperative hypothermia include advanced age, low body weight, extensive surgical exposure, major open or endovascular procedures, large-volume fluid or blood infusion with unwarmed solutions, and use of neuraxial or general anesthesia. Pediatric and geriatric patients are at particular risk due to diminished thermoregulatory capacity. Environmental factors, such as low ambient temperature in the operating room, further compound risk. Hyperthermia risk is heightened in patients with a history of malignant hyperthermia, those receiving triggering agents (e.g., succinylcholine, volatile anesthetics), and individuals with sepsis or thyroid storm. A thorough preoperative risk assessment is essential for targeted preventive strategies.

Clinical Features

Perioperative hypothermia may manifest as shivering, cold extremities, bradycardia, hypotension, altered mental status, and delayed emergence from anesthesia. More subtle signs include coagulopathy, increased blood loss, and metabolic acidosis. In the postoperative period, hypothermia is associated with increased risk of wound infection, myocardial ischemia, and arrhythmias. Hyperthermia, on the other hand, presents with fever, tachycardia, muscle rigidity (in malignant hyperthermia), altered mental status, and, in severe cases, rhabdomyolysis and acute renal failure. Both conditions necessitate prompt recognition and intervention to prevent adverse outcomes.

Diagnosis

Accurate and continuous core temperature monitoring is essential for early detection of perioperative temperature disturbances. Recommended sites include the distal esophagus, nasopharynx, tympanic membrane, or bladder for intraoperative monitoring, and axillary or oral measurements for less invasive settings. Non-core sites may underestimate the degree of hypothermia, particularly during rapid temperature changes. In addition to temperature, monitoring for clinical signs and laboratory markers of coagulopathy, metabolic derangements, and infection is important for comprehensive assessment. Emerging technologies such as zero-heat-flux thermometry and wireless wearable sensors offer promising improvements in accuracy and convenience.

Treatment & Management

The primary goal of perioperative temperature management is the prevention of hypothermia through proactive measures. These include pre-warming patients for at least 30 minutes prior to induction, intraoperative use of forced-air warming blankets, warming of intravenous fluids and irrigation solutions, and maintaining ambient operating room temperatures above 21°C when feasible. Active warming should be initiated for any patient with a core temperature below 36°C or those at high risk. Rewarming should be gradual to avoid afterdrop and cardiovascular instability. Management of hyperthermia involves immediate discontinuation of triggering agents (in malignant hyperthermia), administration of dantrolene, active cooling measures, and supportive care for organ dysfunction. Multimodal strategies tailored to patient and procedural risk profiles yield the best outcomes.

Recent Advances / Emerging Therapies

Recent advances in perioperative temperature management include the development of automated temperature feedback systems, closed-loop warming devices, and non-invasive continuous monitoring technologies. Preoperative patient warming using conductive or convective systems has demonstrated efficacy in reducing the incidence and severity of intraoperative hypothermia. Machine learning algorithms are being explored to predict at-risk patients and guide personalized warming protocols. Enhanced recovery after surgery (ERAS) pathways increasingly incorporate temperature management as a key component. Additionally, research into pharmacologic agents that modulate thermoregulatory thresholds is ongoing, with the potential to complement physical warming techniques in the future.

Guideline Recommendations

Major guidelines, including those from the National Institute for Health and Care Excellence (NICE), the American Society of Anesthesiologists (ASA), and the Association of Perioperative Registered Nurses (AORN), recommend routine preoperative risk assessment, active intraoperative warming, and continuous core temperature monitoring in all patients undergoing anesthesia expected to last more than 30 minutes. Specific targets include maintaining core temperature above 36°C and minimizing exposure to cold environments and unwarmed fluids. Protocols should be adapted to patient population, procedural type, and local resources. Education and interdisciplinary collaboration are emphasized to ensure consistent implementation and audit of temperature management practices.

Conclusion

Effective perioperative temperature management is a vital, evidence-based component of modern surgical care, with significant implications for patient safety and outcomes. Understanding the epidemiology, risk factors, and pathophysiology of temperature disturbances enables clinicians to implement targeted preventive and therapeutic strategies. Adherence to guideline recommendations, combined with adoption of emerging technologies and interdisciplinary collaboration, can minimize morbidity, reduce healthcare costs, and improve surgical recovery. Ongoing research and quality improvement initiatives will further refine best practices in this essential area of perioperative medicine.